The Brain Trust Accelerator Fund focuses on translational stage investments that address the diagnosis and treatment of brain-related diseases. Over its life, Fund I has generated top tier rates of return, resulted in approaches to benefit up to ten million patients with brain diseases, and delivered $500,000 to charities.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions